Cardiovascular Effects of New Oral Glucose-Lowering Agents-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Cardiovascular Effects of New Oral Glucose-Lowering Agents

Published:2018-05-11 Issue:10 Volume:122 Page:1439-1459
ISSN:0009-7330
Container-title:Circulation Research
language:en
Short-container-title:Circ Res

Author:

Scheen André J.¹²

Affiliation:

1. From the Division of Diabetes, Nutrition and Metabolic Disorders, Department of Medicine, CHU Liège, Belgium (A.J.S.)

2. Division of Clinical Pharmacology, Center for Interdisciplinary Research on Medicines (CIRM), University of Liège, Belgium (A.J.S.).

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cardiology and Cardiovascular Medicine,Physiology

Reference180 articles.

1. Diabetes Mellitus, Fasting Glucose, and Risk of Cause-Specific Death

2. Primary Prevention of Cardiovascular Disease in Diabetes Mellitus

3. Changes in Diabetes-Related Complications in the United States, 1990–2010

4. Mortality and Cardiovascular Disease in Type 1 and Type 2 Diabetes

5. Intensive glucose control and macrovascular outcomes in type 2 diabetes

Cited by 233 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Empagliflozin-A Sodium Glucose Co-transporter-2 Inhibitor: Overview of its Chemistry, Pharmacology, and Toxicology;Current Diabetes Reviews;2024-10

2. Association between glucagon‐like peptide‐1 receptor agonists and risk of suicidality: A comprehensive analysis of the global pharmacovigilance database;Diabetes, Obesity and Metabolism;2024-08-19

3. Optimizing Management of Stable Angina;Journal of the American College of Cardiology;2024-08

4. Autonomic modulation by SGLT2i or DPP4i in patients with diabetes favors cardiovascular outcomes as revealed by skin sympathetic nerve activity;Frontiers in Pharmacology;2024-07-30

5. Dual add‐on therapy of gemigliptin and dapagliflozin in patients with type 2 diabetes inadequately controlled with metformin alone: The SOLUTION 2 study;Diabetes, Obesity and Metabolism;2024-07-08

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3